According to Zhitong Finance App, Yasheng Pharmaceutical (06855) issued an announcement. On September 17, 2026, the trustee announced that the 2022 restricted share unit plan aims to purchase a total of 50,000 existing shares on the market to satisfy the restricted share units after ownership.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.